168 related articles for article (PubMed ID: 31169215)
1. Role of hypofractionated palliative radiotherapy in patients with stage four head-and-neck squamous cell carcinoma.
Mudgal A; Arya AK; Yadav I; Chaudhary S
J Cancer Res Ther; 2019; 15(3):528-532. PubMed ID: 31169215
[TBL] [Abstract][Full Text] [Related]
2. "Christie Regimen" palliative radiotherapy in advanced head-and-neck cancer: A single-center experience.
Srivastava A; Adhikari N; Sonkar DR; Singh K; Rathi AK
J Cancer Res Ther; 2021; 17(1):88-93. PubMed ID: 33723137
[TBL] [Abstract][Full Text] [Related]
3. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers.
Murthy V; Kumar DP; Budrukkar A; Gupta T; Ghosh-Laskar S; Agarwal J
Indian J Cancer; 2016; 53(1):138-41. PubMed ID: 27146764
[TBL] [Abstract][Full Text] [Related]
4. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. End stage palliative care of head and neck cancer: a case study.
Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis.
Uttam AK; Yadav AK; Jalota S; Singh R; Malik S; Arya AK
Ecancermedicalscience; 2023; 17():1541. PubMed ID: 37138956
[TBL] [Abstract][Full Text] [Related]
8. Accelerated hypofractionation (OCTA SHOT): Palliative radiation schedule in advanced head and neck carcinoma.
Jakhar SL; Purohit R; Solanki A; Murali P; Kothari T; Sharma N; Kumar HS
J Cancer Res Ther; 2017; 13(6):943-946. PubMed ID: 29237955
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.
Jacinto AA; Batalha Filho ES; Viana LS; De Marchi P; Capuzzo RC; Gama RR; Boldrini Junior D; Santos CR; Pinto GDJ; Dias JM; Canton HP; Carvalho R; Radicchi LA; Bentzen S; Zubizarreta E; Carvalho AL
BMC Cancer; 2018 Oct; 18(1):1026. PubMed ID: 30352576
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
13. Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region.
De Felice F; Musio D; Tombolini V
Radiol Med; 2021 Apr; 126(4):620-622. PubMed ID: 33058025
[TBL] [Abstract][Full Text] [Related]
14. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience.
Das S; Thomas S; Pal SK; Isiah R; John S
Indian J Palliat Care; 2013 May; 19(2):93-8. PubMed ID: 24049349
[TBL] [Abstract][Full Text] [Related]
17. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
[TBL] [Abstract][Full Text] [Related]
18. HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Moon DH; Avkshtol V; Vo D; Ahn C; Sumer B; Day AT; Tillman B; Myers L; Truelson J; Sher DJ
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):157-164. PubMed ID: 37380084
[TBL] [Abstract][Full Text] [Related]
19. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
Elbers JBW; Gunsch PA; Debets R; Keereweer S; van Meerten E; Zindler J; van Norden Y; Hoogeman MS; Verduijn GM; Kroesen M; Nout RA
BMC Cancer; 2023 Jun; 23(1):541. PubMed ID: 37312053
[TBL] [Abstract][Full Text] [Related]
20. Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region.
De Felice F; Serpone M; Cattaneo CG; Di Giammarco F; Fallico A; Delle Donne A; Lanzilao M; Vitti E; Marampon F; Musio D; Tombolini V; Minniti G
J Geriatr Oncol; 2024 Jan; 15(1):101596. PubMed ID: 37517887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
